| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | ETANERCEPT | 5 |
| 2 | AMLODIPINE BESYLATE | 4 |
| 3 | UPADACITINIB | 4 |
| 4 | ALENDRONATE SODIUM | 3 |
| 5 | DUPILUMAB | 3 |
| 6 | IBRUTINIB | 3 |
| 7 | OXYCODONE | 3 |
| 8 | PANCRELIPASE | 3 |
| 9 | PANTOPRAZOLE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 1 | 0.0017 |
| 1 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 2 | ESOMEPRAZOLE SODIUM | 1 | 0.0004 |
| 3 | CEFIXIME | 1 | 0.0003 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | NALOXEGOL OXALATE | 1 | 0.0003 |
| 6 | LARONIDASE | 1 | 0.0002 |
| 7 | ZANUBRUTINIB | 1 | 0.0002 |
| 8 | DASATINIB | 2 | 0.0002 |
| 9 | ALISKIREN HEMIFUMARATE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 1 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Androgen [EPC] | 2 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 8 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 9 | Janus Kinase Inhibitor [EPC] | 4 | 0.0000 |